Progress from Royal Liver has removed two examples of pre-malignant cancers from its critical illness cover following changes made by the Association of British Insurers.
The ABI announced last month it was removing two cancers affecting the blood – known as essential thrombocythaemia and polycythaemia – from its statement of best practice cancer definition as examples of pre-maligancy, as new evidence suggested the two cancers might, in fact, be malignant. Pre-malignant cancers are not covered under critical illness (CI) policies whereas malignant ones are. Royal Liver is applying the change retrospectively to any IFA customers who purchased life cover with guaranteed CI cover from the provider from 15 October – the date it implemented the ABI’s new bes...
To continue reading this article...
Join Professional Adviser for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes
